BTS clinical statement for the diagnosis and management of ocular tuberculosis
- PMID: 35379660
- PMCID: PMC9021811
- DOI: 10.1136/bmjresp-2022-001225
BTS clinical statement for the diagnosis and management of ocular tuberculosis
Abstract
The BTS clinical statement for the diagnosis and management of ocular tuberculosis (TB) draws on the expertise of both TB and and ophthalmic specialists to outline the current understanding of disease pathogenesis, diagnosis and management in adults. Published literature lacks high-quality evidence to inform clinical practice and there is also a paucity of data from animal models to elucidate mechanisms of disease. However, in order to improve and standardise patient care, this statement provides consensus points with the currently available data and agreed best practice.
Keywords: tuberculosis.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: Funding has been declared from: DC, Insmed; OMK Boehringer Ingelheim, Oxford Immunotech, Cepheid, Qiagen; alal other authors have no declared interests.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources